Genta-Aventis Case Study: Failing Strategies Within Late Stage Vertical Licensing
| Формат: | Цахим Сэтгүүл |
|---|---|
| Хэл сонгох: | англи |
| Хэвлэсэн: |
MarketLine, a Progressive Digital Media business
|
| Онлайн хандалт: | Full text available on EBSCOhost[Nov 2005-Nov 2005 |
Ижил төстэй зүйлс
IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
Roche-Kosan Case Study: Successful Early Licensing Strategies
Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
Aventis SWOT Analysis
Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio
Sanofi-Aventis SWOT Analysis
Licensing Loyalty
-н: McLeod
-н: McLeod
License to Play
-н: Daliot-Bul
-н: Daliot-Bul
License to Wed
-н: Richman
-н: Richman
Licensing Journal
Failing Families, Failing Science
-н: Lincoln
-н: Lincoln
Licensed Practical Nurse
Vertical Reefs
-н: Wicksten
-н: Wicksten
Lipitor Case Study: Lifecycle Management Strategies
Failed Frontiersmen
-н: Donahue
-н: Donahue
Words Fail
-н: Dickinson
-н: Dickinson
The Revolution that Failed
-н: Fairclough
-н: Fairclough
Failed Evidence
-н: Harris
-н: Harris
Failed Promises
-н: Konisky
-н: Konisky
IPO Exit Strategies Case Study: Undertaking a Successful IPO Exit Strategy
Staging Harmony
-н: Brokaw
-н: Brokaw
Staging Asia
-н: Kuruppath
-н: Kuruppath
Setting the Stage
-н: Hays
-н: Hays
Subversive Stages
-н: Komporaly
-н: Komporaly
Staging Revolution
-н: Fan
-н: Fan
Occupying the Stage
-н: Bredeson
-н: Bredeson
Staging Family
-н: Mullenneaux
-н: Mullenneaux
Staging the Amistad
-н: Christensen
-н: Christensen
On Stage Alone
-н: Gitelman
-н: Gitelman
Staging Ghana
-н: Schauert
-н: Schauert
Stage for Action
-н: Dail
-н: Dail
The Stages of Memory
-н: Young
-н: Young
Ижил төстэй зүйлс
- IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
- Roche-Kosan Case Study: Successful Early Licensing Strategies
- Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
- Aventis SWOT Analysis
- Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio